·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Çѱ¹¾²¸®¿¥, 'ÅÆº¸ÄÚÁ¤' ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ±â»çÀÔ·Â : 07.07.31 16:41:29 0 °¡ ÇÃÄ£Ãß°¡ ½Ä¾àû, 31ÀÏÀÚ ¼ö¸®...Áß¿ÜÁ¦¾à¿¡ ¾çµµ¾ç¼ö »çÀ¯ ºÎÁ¤¸Æ¿ëÁ¦ÀÎ Çѱ¹¾²¸®¿¥ÀÇ 'ÅÆº¸ÄÚÁ¤(¼ººÐ ÃÊ»êÇ÷¹Ä«À̴ϵå)'ÀÇ Ç°¸ñÇã°¡°¡ ÃëÇϵƴÙ. ½Ä¾àûÀº 31ÀÏ ¾²¸®¿¥ÀÇ ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ¿äûÀ» ¼ö¸®Çß´Ù°í ¹àÇû´Ù. À̹ø Çã°¡ÃëÇÏ´Â ¾²¸®¿¥ÀÌ ÅÆº¸ÄÚÁ¤À» Áß¿ÜÁ¦¾à¿¡ ¾çµµ¡¤¾ç¼öÇѵ¥ µû¸¥ ÈļÓÁ¶Ä¡´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѱ¹¾²¸®¿¥, ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѱ¹¾²¸®¿¥, 'ÅÆº¸ÄÚÁ¤' ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ±â»çÀÔ·Â : 07.07.31 16:41:29 0 °¡ ÇÃÄ£Ãß°¡ ½Ä¾àû, 31ÀÏÀÚ ¼ö¸®...Áß¿ÜÁ¦¾à¿¡ ¾çµµ¾ç¼ö »çÀ¯ ºÎÁ¤¸Æ¿ëÁ¦ÀÎ Çѱ¹¾²¸®¿¥ÀÇ 'ÅÆº¸ÄÚÁ¤(¼ººÐ ÃÊ»êÇ÷¹Ä«À̴ϵå)'ÀÇ Ç°¸ñÇã°¡°¡ ÃëÇϵƴÙ. ½Ä¾àûÀº 31ÀÏ ¾²¸®¿¥ÀÇ ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ¿äûÀ» ¼ö¸®Çß´Ù°í ¹àÇû´Ù. À̹ø Çã°¡ÃëÇÏ´Â ¾²¸®¿¥ÀÌ ÅÆº¸ÄÚÁ¤À» Áß¿ÜÁ¦¾à¿¡ ¾çµµ¡¤¾ç¼öÇѵ¥ µû¸¥ ÈļÓÁ¶Ä¡´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѱ¹¾²¸®¿¥, ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѱ¹¾²¸®¿¥, 'ÅÆº¸ÄÚÁ¤' ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ±â»çÀÔ·Â : 07.07.31 16:41:29 0 °¡ ÇÃÄ£Ãß°¡ ½Ä¾àû, 31ÀÏÀÚ ¼ö¸®...Áß¿ÜÁ¦¾à¿¡ ¾çµµ¾ç¼ö »çÀ¯ ºÎÁ¤¸Æ¿ëÁ¦ÀÎ Çѱ¹¾²¸®¿¥ÀÇ 'ÅÆº¸ÄÚÁ¤(¼ººÐ ÃÊ»êÇ÷¹Ä«À̴ϵå)'ÀÇ Ç°¸ñÇã°¡°¡ ÃëÇϵƴÙ. ½Ä¾àûÀº 31ÀÏ ¾²¸®¿¥ÀÇ ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ ¿äûÀ» ¼ö¸®Çß´Ù°í ¹àÇû´Ù. À̹ø Çã°¡ÃëÇÏ´Â ¾²¸®¿¥ÀÌ ÅÆº¸ÄÚÁ¤À» Áß¿ÜÁ¦¾à¿¡ ¾çµµ¡¤¾ç¼öÇѵ¥ µû¸¥ ÈļÓÁ¶Ä¡´Ù. X AD ·Î°ÔÀÎÆû ¸ð¸àÅ͸® À̺¥Æ®Âü¿© ¡æ ¹ÚÂùÇÏ ±âÀÚ(chpark@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѱ¹¾²¸®¿¥, ÅÆº¸ÄÚÁ¤ ǰ¸ñÇã°¡ ÀÚÁøÃëÇÏ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö